logo

Intercept Pharmaceuticals Inc. (ICPT)



Trade ICPT now with
  Date
  Headline
9/15/2017 9:49:34 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Ourperform With $253 Price Target
8/25/2017 9:07:07 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Outperform With $253 Price Target
8/18/2017 6:54:52 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Outperform With $253 Price Target
7/31/2017 7:13:25 AM Intercept Pharma Q2 Net Loss $86.56 Mln Or $3.46/Shr Vs Loss$77.3 Mln Or $3.14/Shr Last Year
7/31/2017 7:09:22 AM Intercept Announces Positive Results From Phase 2 AESOP Trial Evaluating OCA For Primary Sclerosing Cholangitis
6/23/2017 9:37:53 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Outperform With $231 Price Target
6/16/2017 11:41:53 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Outperform With $231 Price Target
6/13/2017 6:54:38 AM Wedbush Is Raising Intercept Pharmaceuticals Inc. (ICPT) 2018 Estimate To -11.28 From -12.09
6/13/2017 6:54:08 AM Wedbush Is Raising Intercept Pharmaceuticals Inc. (ICPT) Q4 18 Estimate To -2.09 From -2.32
6/13/2017 6:53:48 AM Wedbush Is Raising Intercept Pharmaceuticals Inc. (ICPT) Q3 18 Estimate To -2.57 From -2.87
6/13/2017 6:53:23 AM Wedbush Is Raising Intercept Pharmaceuticals Inc. (ICPT) Q2 18 Estimate To -3.06 From -3.30
6/13/2017 6:53:05 AM Wedbush Is Increasing Intercept Pharmaceuticals Inc. (ICPT) Q1 18 Estimate To -3.57 From -3.61
6/13/2017 6:52:40 AM Wedbush Is Increasing Intercept Pharmaceuticals Inc. (ICPT) 2017 Estimate To -14.67 From -16.13
6/13/2017 6:52:13 AM Wedbush Is Raising Intercept Pharmaceuticals Inc. (ICPT) Q4 17 Estimate To -3.67 From -3.85
6/13/2017 6:51:52 AM Wedbush Is Raising Intercept Pharmaceuticals Inc. (ICPT) Q3 17 Estimate To -3.72 From -4.01
6/13/2017 6:51:35 AM Wedbush Is Increasing Intercept Pharmaceuticals Inc. (ICPT) Q2 17 Estimate To -3.68 From -4.08
6/13/2017 6:50:53 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Ourperform With $231 Price Target